ARAY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ARAY is not a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to deploy. The stock is trading near penny-stock levels, the technical trend is bearish, analyst sentiment has turned negative, and there is no recent news catalyst or sign of institutional accumulation. Even though options activity is heavily skewed to calls, the overall setup does not support a confident long-term entry today. My direct view: do not buy now.
ARAY is in a clear bearish trend. The MACD histogram is negative and still contracting, the moving averages are bearish with SMA_200 > SMA_20 > SMA_5, and price is trading below the pivot at 0.297 and just under the first support zone near 0.258. RSI_6 at 20.204 shows the stock is deeply oversold, but oversold alone is not a buy signal when trend and momentum remain weak. The stock pattern data also points to weakness, with an estimated 70% chance of declines over the next day, week, and month.
No news in the recent week. The only mildly positive factor is that the stock is deeply oversold technically, which could support a short-term bounce. Options open interest is strongly call-skewed, which can sometimes indicate speculative upside interest, but it is not strong enough to override the broader negative setup.
Jefferies downgraded the stock to Hold from Buy and cut the target to $0.35, citing the fiscal Q3 miss, withdrawal of fiscal-year guidance, Middle East shipment delays, and ongoing China joint venture uncertainty. BTIG also downgraded to Neutral, noting weak product revenue, another adjusted EBITDA miss, and limited visibility on a turnaround. There is no recent news catalyst, hedge funds are neutral, insiders are neutral, and there is no recent congress trading data. The stock also has very poor forward pattern expectations and remains below key resistance levels.
No usable latest-quarter financial snapshot was provided because of a data error, but the analyst commentary indicates the latest quarter was weak, with a fiscal Q3 miss and management withdrawing full-year guidance. The mention of declining revenue, missed adjusted EBITDA expectations, and continued uncertainty around shipments suggests deteriorating recent quarter fundamentals rather than improving growth.
Analyst trend is negative. Jefferies downgraded ARAY to Hold from Buy and slashed the target from $3.05 to $0.35 due to fiscal Q3 miss and guidance withdrawal. BTIG also downgraded it to Neutral from Buy because of revenue decline, missed EBITDA, and weak visibility. The Wall Street pros view is mostly bearish: the main cons are weak growth, geopolitical disruption, and poor predictability; the only pro is that cost-cutting is ahead of schedule.
